, Figure III.5.7 -Time Variation -YPLL80

, Note -This figure shows how Years of Potential Life Lost (age reference = 80) varies depending on the length of time to drug launch. The model includes disease fixed effects and year fixed effects. The graph includes 90% two-sided confidence intervals. Orphan Drugs and Longevity in the US

, name ICD-10, Disease name ICD-10, 1999.

, Orphan Drugs and Longevity in the US Revisited name ICD-10, 1999.

, publication_dates = open('publication_dates.csv', 'w') for code_maladie

N. K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull et al., The European Organization for Research and Treatment of Cancer QLQ-Cc30: A quality-of-life instrument for use in international clinical trials in oncology, JNCI: Journal of the National Cancer Institute, vol.85, issue.5, p.43, 1993.

P. Aghion, P. Howitt, and F. Murtin, The relationship between health and growth: When Lucas meets Nelson-Phelps, p.157, 2010.

C. Ai and E. C. Norton, Interaction terms in logit and probit models, Economics letters, vol.80, issue.1, pp.123-129, 2003.

A. Maladies-rares and A. , Rapport d'activité 2016 de l'alliance maladies rares, vol.58, 2016.

S. Allin, M. Grignon, L. Grand, and J. , Subjective unmet need and utilization of health care services in Canada: What are the equity implications?, Social Science & Medicine, vol.70, issue.3, pp.465-472, 2010.

D. Anderson, S. Dumont, P. Jacobs, A. , and L. , The personal costs of caring for a child with a disability: A review of the literature, Public Health Reports, vol.122, issue.1, pp.3-16, 2007.

L. R. Anderson and J. M. Mellor, Predicting health behaviors with an experimental measure of risk preference, Journal of Health Economics, vol.27, issue.5, p.61, 2008.

A. Anell, Priority setting for pharmaceuticals, The European Journal of Health Economics, formerly: HEPAC, vol.5, issue.1, pp.28-35, 2004.

J. D. Angrist and J. Pischke, Mostly harmless econometrics: An empiricist's companion, p.136, 2008.

M. Arellano and S. Bond, Some tests of specification for panel data: Monte carlo evidence and an application to employment equations, The Review of Economic Studies, vol.58, issue.2, pp.277-297, 1991.

L. Arrondel and A. Masson, Mesurer les préférences desépargnants: comment et pourquoi (en temps de crise, Economie et Statistique, vol.467, pp.5-49, 2014.

L. Arrondel and A. Masson, Inégalités patrimoniales et choix individuels: des goûts et des richesses, p.65, 2007.

L. Arrondel, A. Masson, and D. Verger, Mesurer les préférences individuellesà l'égard du risque, Économie et Statistique, vol.374, issue.1, pp.53-85, 2004.

. Bibliography,

L. Arrondel, A. Masson, and D. Verger, Préférences de l'épargnant et accumulation patrimoniale, Economie et Statistique, vol.5, pp.374-375, 2004.

K. J. Arrow, Uncertainty and the welfare economics of medical care: Reply (The implications of transaction costs and adjustment lags), The American Economic Review, vol.55, issue.1, pp.154-158, 1963.

D. H. Autor, Outsourcing at will: The contribution of unjust dismissal doctrine to the growth of employment outsourcing, Journal of Labor Economics, vol.21, issue.1, pp.1-42, 2003.

S. Auvin, J. Irwin, P. Abi-aad, and A. Battersby, The problem of rarity: Estimation of prevalence in rare disease, Value in Health, vol.21, issue.5, p.45, 2018.

G. Baetschmann, K. E. Staub, and R. Winkelmann, Consistent estimation of the fixed effects ordered logit model, Journal of the Royal Statistical Society: Series A (Statistics in Society), vol.178, issue.3, pp.685-703, 2015.

K. Baicker and A. Chandra, The productivity of physician specialization: Evidence from the medicare program, American Economic Review, vol.94, issue.2, pp.357-361, 2004.

K. Ballard, K. Lowton, W. , and J. , What's the delay? A qualitative study of women's experiences of reaching a diagnosis of endometriosis, Fertility and Sterility, vol.86, issue.5, p.40, 2006.

A. I. Balsa and T. G. Mcguire, Prejudice, clinical uncertainty and stereotyping as sources of health disparities, Journal of health economics, vol.22, issue.1, pp.89-116, 2003.

A. I. Balsa, T. G. Mcguire, and L. S. Meredith, Testing for statistical discrimination in health care, Health Services Research, vol.40, issue.1, pp.227-252, 2005.

R. Barouki, P. D. Gluckman, P. Grandjean, M. Hanson, and J. J. Heindel, Developmental origins of non-communicable disease: Implications for research and public health, Environmental Health, vol.11, issue.1, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00712586

A. Basu and D. Meltzer, Implications of spillover effects within the family for medical costeffectiveness analysis, Journal of Health Economics, vol.24, issue.4, pp.751-773, 2005.

S. Bavisetty, W. W. Grody, and S. Yazdani, Emergence of pediatric rare diseases. Rare Diseases, 1, vol.170, p.254, 2013.

G. Baynam, N. Pachter, F. Mckenzie, S. Townshend, J. Slee et al., The rare and undiagnosed diseases diagnostic service-application of massively parallel sequencing in a state-wide clinical service, Orphanet Journal of Rare Diseases, vol.11, issue.1, 2016.

G. S. Becker, A theory of social interactions, Journal of Political Economy, vol.82, issue.6, pp.1063-1093, 1974.

C. Benoît, Les convergences parallèles: uneéconomie politique de la régulation de l'accès au marché des médicaments en France et en Angleterre, vol.249, p.250, 2016.

J. ,. Bentham, Utilitarianism and Other Essays, 2004.

L. R. Berney and D. B. Blane, Collecting retrospective data: accuracy of recall after 50 years judged against historical records, Social Science & Medicine, vol.45, issue.10, pp.1519-1525, 1997.

D. M. Blau and P. K. Robins, Fertility, employment, and child-care costs, Demography, vol.26, issue.2, pp.287-299, 1989.

Å. Blomqvist, The doctor as double agent: Information asymmetry, health insurance, and medical care, Journal of Health Economics, vol.10, issue.4, pp.411-432, 1991.

R. Blundell and M. C. Dias, Alternative approaches to evaluation in empirical microeconomics, Portuguese Economic Journal, vol.1, issue.2, pp.91-115, 2002.

A. Bobinac, N. J. Van-exel, F. F. Rutten, and W. B. Brouwer, Caring for and caring about: Disentangling the caregiver effect and the family effect, Journal of Health Economics, vol.29, issue.4, pp.549-556, 2010.

J. Bom, P. Bakx, E. Schut, and E. E. Van-doorslaer, Health effects of caring for and about parents and spouses. Tinbergen Institute Discussion Papers 18-050/V, Tinbergen Institute, p.96, 2018.

V. L. Bonham, Race, ethnicity, and pain treatment: Striving to understand the causes and solutions to the disparities in pain treatment, The Journal of Law, vol.28, issue.4, p.69, 2001.

E. Bonsang, Does informal care from children to their elderly parents substitute for formal care in Europe, Journal of Health Economics, vol.28, issue.1, pp.143-154, 2009.

L. E. Bothwell, J. A. Greene, S. H. Podolsky, and D. S. Jones, Assessing the gold standard -Lessons from the history of RCTs, New England Journal of Medicine, vol.374, p.48, 2016.

P. Bourdieu, Le capital social. Actes de la recherche en sciences sociales, vol.31, 1980.

K. M. Boycott, M. R. Vanstone, D. E. Bulman, and A. E. Mackenzie, Rare-disease genetics in the era of next-generation sequencing: Discovery to translation, Nature Reviews Genetics, vol.14, issue.10, p.46, 2013.

P. Brañas-garza, V. Capraro, and E. Rascón-ramírez, Gender differences in altruism: Expectations, actual behaviour and accuracy of beliefs, 2016.

P. Brañas-garza, V. Capraro, and E. Rascon-ramirez, Gender differences in altruism on mechanical turk: Expectations and actual behaviour, Economics Letters, vol.170, pp.19-23, 2018.

P. Braveman and E. Tarimo, Social inequalities in health within countries: Not only an issue for affluent nations, Social Science & Medicine, vol.54, issue.11, p.42, 2002.

J. Brazier, D. Rowen, C. Mukuria, S. Whyte, A. Keetharuth et al., Eliciting societal preferences for burden of illness, therapeutic improvement and end of life for value based pricing: a report of the main survey, vol.157, 2013.

B. M. Buckley, Clinical trials of orphan medicines, The Lancet, vol.371, issue.9629, p.124, 2008.

M. J. Bibliography-burton, Commentary: Tonsillectomy-Then and now, International Journal of Epidemiology, vol.37, issue.1, pp.23-25, 2008.

M. Byrne, D. Hurley, L. Daly, and C. Cunningham, Health status of caregivers of children with cerebral palsy. Child: Care, Health and Development, vol.36, pp.696-702, 2010.

A. Caqueo-urízar, J. Gutiérrez-maldonado, and C. Miranda-castillo, Quality of life in caregivers of patients with schizophrenia: A literature review, Health and Quality of Life Outcomes, vol.7, issue.1, p.86, 2009.

F. Carmichael and S. Charles, Benefit payments, informal care and female labour supply, Applied Economics Letters, vol.10, issue.7, pp.411-415, 2003.

A. Chandra, C. Garthwaite, and A. D. Stern, Characterizing the drug development pipeline for precision medicines, National Bureau of Economic Research, vol.30, p.125, 2017.

A. Chandra, J. Gruber, and R. Mcknight, Patient cost-sharing and hospitalization offsets in the elderly, American Economic Review, vol.100, issue.1, pp.193-213, 2010.

E. N. Chapman, A. Kaatz, and M. Carnes, Physicians and implicit bias: How doctors may unwittingly perpetuate health care disparities, Journal of General Internal Medicine, vol.28, issue.11, 2013.

G. Charness, U. Gneezy, and A. Imas, Experimental methods: Eliciting risk preferences, Journal of Economic Behavior & Organization, vol.87, p.61, 2013.

Z. Chen, W. King, R. Pearcey, M. Kerba, and W. J. Mackillop, The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature, Radiotherapy and Oncology, vol.87, issue.1, p.42, 2008.

K. Chevreul, K. B. Brigham, M. Michel, G. Rault, and B. R. Network, Costs and healthrelated quality of life of patients with cystic fibrosis and their carers in france, Journal of Cystic Fibrosis, vol.14, issue.3, p.43, 2015.

L. Chwastiak, D. M. Ehde, L. E. Gibbons, M. Sullivan, J. D. Bowen et al., Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample, American Journal of Psychiatry, vol.159, issue.11, pp.1862-1868, 2002.

O. Ciani and C. Jommi, The role of health technology assessment bodies in shaping drug development. Drug Design, Development and Therapy, vol.8, p.48, 2014.

A. Clark and F. Etilé, Do health changes affect smoking? Evidence from British panel data, Journal of Health Economics, vol.21, issue.4, pp.533-562, 2002.

K. Claxton, S. Martin, M. Soares, N. Rice, E. Spackman et al., Methods for the estimation of the N|ational Institute for Health and Care Excellence cost-effectiveness threshold, Health Technology Assessment, vol.19, issue.14, p.250, 2015.

K. Claxton, S. Martin, M. O. Soares, N. Rice, D. E. Spackman et al., Methods for the estimation of the NICE cost effectiveness threshold, vol.244, p.248, 2013.

K. Claxton, M. Sculpher, S. Palmer, and A. J. Culyer, Causes for concern: Is NICE failing to uphold its responsibilities to all NHS patients?, Health Economics, vol.24, issue.1, pp.1-7, 2015.

K. P. Claxton, J. R. Lomas, M. , and S. , The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all-cause and disease specific models of mortality. Health Economics, p.248, 2018.

I. Cockburn, Is the Pharmaceutical Industry in a Productivity Crisis? Chapter, p.139, 2007.

J. Cohen and W. Looney, What is the value of oncology medicines?, Nature Biotechnology, vol.28, issue.11, pp.1160-1163, 2010.

S. Cohen, Social relationships and health, American Pychologist, vol.59, issue.8, 2004.

J. S. Coleman, Social capital in the creation of human capital, American Journal of Sociology, vol.94, 1988.

R. Cookson and P. Dolan, Principles of justice in health care rationing, Journal of Medical Ethics, vol.26, issue.5, pp.323-329, 2000.

H. Cooper, K. Booth, and G. Gill, Patients' perspectives on diabetes health care education, Health Education Research, vol.18, issue.2, pp.191-206, 2003.

H. Corcnan, K. Noonan, and N. E. Reichman, Mothers' labor supply in fragile families: The role of child health, Eastern Economic Journal, vol.31, issue.4, pp.601-616, 2005.

T. Correa, A. W. Hinsley, D. Zuniga, and H. G. , Who interacts on the Web?: The intersection of users' personality and social media use, Computers in Human Behavior, vol.26, issue.2, pp.247-253, 2010.

A. Côté and B. Keating, What is wrong with orphan drug policies? Value in Health, vol.15, p.50, 2012.

D. R. Cox, Regression models and life-tables, Breakthroughs in Statistics, pp.527-541, 1992.

. Springer, , p.66

L. Craig, Does father care mean fathers share? A comparison of how mothers and fathers in intact families spend time with children, Gender & Society, vol.20, issue.2, pp.259-281, 2006.

J. Currie, Healthy, wealthy, and wise: Socioeconomic status, poor health in childhood, and human capital development, Journal of Economic Literature, vol.47, issue.1, pp.87-122, 2009.

D. M. Cutler and A. Lleras-muney, Understanding differences in health behaviors by education, Journal of Health Economics, vol.29, issue.1, pp.1-28, 2010.

H. Bibliography-dakin, N. Devlin, Y. Feng, N. Rice, P. O'neill et al., The influence of costeffectiveness and other factors on nice decisions, Health Economics, vol.24, issue.10, p.249, 2015.

H. J. Dawkins, R. Draghia-akli, P. Lasko, L. P. Lau, A. H. Jonker et al., Progress in rare diseases research 2010-2016: An IRDiRC perspective, vol.11, 2018.

C. De-chaisemartin and X. Haultfoeuille, Two-way fixed effects estimators with heterogeneous treatment effects, 2018.

D. De-walque, Does education affect smoking behaviors?: Evidence using the Vietnam draft as an instrument for college education, Journal of Health Economics, vol.26, issue.5, pp.877-895, 2007.

S. Desai and S. Alva, Maternal education and child health: Is there a strong causal relationship? Demography, vol.35, pp.71-81, 1998.

C. Després, P. Dourgnon, R. Fantin, J. , and F. , Le renoncement aux soins pour raisons financières: une approcheéconométrique. Irdes, Questions d'économie de la santé, vol.170, p.60, 2011.

M. Devaux, F. Jusot, C. Sermet, and S. Tubeuf, Hétérogénéité sociale de déclaration de l'état de santé et mesure des inégalités de santé, Revue française des affaires sociales, vol.87, pp.29-47, 2008.

P. J. Devereux and R. A. Hart, Forced to be rich? Returns to compulsory schooling in Britain, The Economic Journal, vol.120, issue.549, pp.1345-1364, 2010.

N. Devlin and D. Parkin, Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis, Health Economics, vol.13, issue.5, pp.437-452, 2004.

B. Hombres, L. Rocco, M. Suhrcke, and M. Mckee, Does social capital determine health? Evidence from eight transition countries, Health Economics, vol.19, issue.1, p.61, 2010.

A. D'houtaud and M. G. Field, The image of health: Variations in perception by social class in a French population, Sociology of Health & Illness, vol.6, issue.1, p.69, 1984.

M. Dickie and V. L. Messman, Parental altruism and the value of avoiding acute illness: Are kids worth more than parents, Journal of Environmental Economics and Management, vol.48, issue.3, pp.1146-1174, 2004.

R. C. Dillehay and M. R. Sandys, Caregivers for Alzheimer's patients: What we are learning from research, The International Journal of Aging and Human Development, vol.30, issue.4, pp.263-285, 1990.

J. A. Dimasi, H. G. Grabowski, and R. W. Hansen, Innovation in the pharmaceutical industry: New estimates of R&D costs, Journal of Health Economics, vol.47, pp.20-33, 2016.

J. A. Dimasi, R. W. Hansen, and H. G. Grabowski, The price of innovation: New estimates of drug development costs, Journal of Health Economics, vol.22, issue.2, p.129, 2003.

P. Dixon, C. Chamberlain, and W. Hollingworth, Did it matter that the cancer drugs fund was not NICE? A retrospective review, Value in Health, vol.19, issue.6, pp.879-884, 2016.

D. Doiron, D. G. Fiebig, M. Johar, and A. Suziedelyte, Does self-assessed health measure health?, Applied Economics, vol.47, issue.2, pp.180-194, 2015.

P. Dolan, Thinking about it: thoughts about health and valuing qalys, Health Economics, vol.20, issue.12, pp.1407-1416, 2011.

A. Dreber, D. Fudenberg, R. , and D. G. , Who cooperates in repeated games: The role of altruism, inequity aversion, and demographics, Journal of Economic Behavior & Organization, vol.98, pp.41-55, 2014.

M. Drummond and A. Towse, Orphan drugs policies: A suitable case for treatment: Editorial, European Journal of Health Economics, vol.15, issue.4, pp.335-340, 2014.

M. F. Drummond, D. A. Wilson, P. Kanavos, P. Ubel, and J. Rovira, Assessing the economic challenges posed by orphan drugs, International journal of technology assessment in health care, vol.23, issue.1, pp.36-42, 2007.

P. Dubois, O. De-mouzon, F. Scott-morton, and P. Seabright, Market size and pharmaceutical innovation, The RAND Journal of Economics, vol.46, issue.4, pp.844-871, 2015.

J. W. Dwyer, G. R. Lee, and T. B. Jankowski, Reciprocity, elder satisfaction, and caregiver stress and burden: The exchange of aid in the family caregiving relationship, Journal of Marriage and the Family, vol.27, p.43, 1994.

E. European-medicines-agency, European medicines agency. committee for medicinal products for human use, vol.29, p.45, 2013.

N. C. Facione, Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay, Social Science & Medicine, vol.36, issue.12, pp.1521-1534, 1993.

I. Fajardy and H. Michel, Difficultés diagnostiques de l'hémochromatose génétique hfe (retard, excès, absence): point de vue du malade, Annales de Biologie Clinique, vol.70, pp.492-495, 2012.

M. J. Field and T. F. Boat, Profile of Rare Diseases, p.152, 2010.

A. Finkelstein, Static and dynamic effects of health policy: Evidence from the vaccine industry, The Quarterly Journal of Economics, vol.119, issue.2, pp.527-564, 2004.

R. Fontaine, A. Gramain, and J. Wittwer, Providing care for an elderly parent: interactions among siblings? Health economics, vol.18, pp.1011-1029, 2009.

C. Foot, C. Naylor, and C. Imison, The quality of gp diagnosis and referral, p.70, 2010.

M. W. Friedberg, P. S. Hussey, and E. C. Schneider, Primary care: a critical review of the evidence on quality and costs of health care, vol.29, pp.766-772, 2010.

A. Bibliography-fuat, A. P. Hungin, and J. J. Murphy, Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study, Bmj, vol.326, issue.7382, 2003.

A. Gafni and G. W. Torrance, Risk attitude and time preference in health, Management Science, vol.30, issue.4, p.61, 1984.

S. Galperti and B. Strulovici, A theory of intergenerational altruism, Econometrica, vol.85, issue.4, pp.1175-1218, 2017.

P. García-gómez, Institutions, health shocks and labour market outcomes across Europe, Journal of Health Economics, vol.30, issue.1, p.95, 2011.

P. García-gómez and Á. López-nicolás, Health shocks, employment and income in the Spanish labour market, Health Economics, vol.15, issue.9, pp.997-1009, 2006.

P. García-gómez, H. Van-kippersluis, O. O'donnell, and E. Van-doorslaer, Long-term and spillover effects of health shocks on employment and income, Journal of Human Resources, vol.48, issue.4, pp.873-909, 2013.

L. P. Garrison, S. Kamal-bahl, and A. Towse, Toward a broader concept of value: Identifying and defining elements for an expanded cost-effectiveness analysis, Value in Health, vol.20, issue.2, pp.213-216, 2017.

L. P. Garrison and M. F. Austin, Linking pharmacogenetics-based diagnostics and drugs for personalized medicine, vol.25, pp.1281-1290, 2006.

J. M. Gelfand, R. Weinstein, S. B. Porter, A. L. Neimann, J. A. Berlin et al., , 2005.

, Prevalence and treatment of psoriasis in the United Kingdom: A population-based study, Archives of Dermatology, vol.141, issue.12, pp.1537-1541

Y. Gerber, Y. Benyamini, U. Goldbourt, and Y. Drory, Neighborhood socioeconomic context and long-term survival after myocardial infarction, Circulation, vol.121, issue.3, pp.375-383, 2010.

C. A. Gericke, A. Riesberg, and R. Busse, Ethical issues in funding orphan drug research and development, Journal of Medical Ethics, vol.31, issue.3, pp.164-168, 2005.

P. Gertler, Do conditional cash transfers improve child health? Evidence from PROGRESA's control randomized experiment, American Economic Review, vol.94, issue.2, pp.336-341, 2004.

V. Giannuzzi, R. Conte, A. Landi, S. A. Ottomano, D. Bonifazi et al., Orphan medicinal products in europe and united states to cover needs of patients with rare diseases: an increased common effort is to be foreseen, Orphanet Journal of Rare Diseases, issue.1, p.12, 2017.

V. Giannuzzi, R. Conte, A. Landi, S. A. Ottomano, D. Bonifazi et al., Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: An increased common effort is to be foreseen, Orphanet Journal of Rare Diseases, vol.12, issue.1, p.125, 2017.

E. L. Glaeser, D. Laibson, and B. Sacerdote, An economic approach to social capital, The Economic Journal, issue.483, p.61, 2002.

J. A. Glover, The incidence of tonsillectomy in school children, International Journal of Epidemiology, vol.37, issue.1, p.57, 2008.

M. Goldberg, M. Melchior, A. Leclerc, and F. Lert, Les déterminants sociaux de la santé: apports récents de l'épidémiologie sociale et des sciences sociales de la santé, Sciences sociales et santé, vol.20, issue.4, pp.75-128, 2002.

D. Goldman and J. P. Smith, The increasing value of education to health, Social Science & Medicine, vol.72, issue.10, pp.1728-1737, 2011.

D. P. Goldman and J. P. Smith, Can patient self-management help explain the SES health gradient, Proceedings of the National Academy of Sciences, vol.99, pp.10929-10934, 2002.

F. K. Goodwin and K. R. Jamison, Manic-depressive illness: Bipolar disorders and recurrent depression, vol.1, p.64, 2007.

R. Gordon, L. Mcdermott, M. Stead, A. , and K. , The effectiveness of social marketing interventions for health improvement: What's the evidence? Public Health, vol.120, pp.1133-1139, 2006.

P. Gorry and D. Useche, Orphan drug designations as valuable intangible assets for ipo investors in pharma-biotech companies, Economic Dimensions of Personalized and Precision Medicine, vol.33, p.50, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02152424

P. Gorry and D. Useche, Orphan drug designations as valuable intangible assets for IPO investors in pharma-biotech companies, Economic Dimensions of Personalized and Precision Medicine, p.140, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02152424

E. Gould, Decomposing the effects of children's health on mother's labor supply: Is it time or money? Health Economics, vol.13, p.97, 2004.

M. Gouyon, L'enquête sur le recours au spécialiste en médecine de ville en 2007. DREES, document de travail, vol.69, pp.1-173, 2010.

L. Graham and A. J. Oswald, Hedonic capital, adaptation and resilience, Journal of Economic Behavior & Organization, vol.76, issue.2, pp.372-384, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00870190

H. Gravestock, K. Mcdowell, V. , and D. , Counting the costs of cancer, vol.85, 2011.

T. Greulich, S. Ottaviani, R. Bals, P. M. Lepper, C. Vogelmeier et al., Alpha1-antitrypsin deficiency-diagnostic testing and disease awareness in Germany and Italy, Respiratory Medicine, vol.107, issue.9, p.45, 2013.

R. C. Griggs, M. Batshaw, M. Dunkle, R. Gopal-srivastava, E. Kaye et al., Clinical research for rare disease: Opportunities, challenges, and solutions, Molecular Genetics and Metabolism, vol.96, issue.1, p.202, 2009.

P. P. Bibliography-groenewegen, P. Dourgnon, S. Greß, A. Jurgutis, and S. Willems, Strengthening weak primary care systems: Steps towards stronger primary care in selected Western and Eastern European countries, Health Policy, vol.113, issue.1, pp.170-179, 2013.

M. Grossman, On the concept of health capital and the demand for health, Journal of Political Economy, vol.80, issue.2, pp.223-255, 1972.

F. Guillemin, A. Leplège, S. Briançon, E. Spitz, and J. Coste, Perceived health and adaptation in chronic disease, vol.87, 2017.

J. Guo, S. Raïs-ali, and L. Rochaix, Social capital and health interventions: Enhancing social capital to improve health. In Elgar Companion to Social Capital and Health, p.253, 2018.
URL : https://hal.archives-ouvertes.fr/halshs-01885679

R. Hadfield, H. Mardon, D. Barlow, K. , and S. , Delay in the diagnosis of endometriosis: A survey of women from the USA and the UK, Human Reproduction, vol.11, issue.4, p.40, 1996.

, Rapport de mandature de la commissionévaluationéconomique et santé publique, HAS, p.242, 2018.

R. P. Hastings and T. Brown, Behavior problems of children with autism, parental self-efficacy, and mental health, American Journal on Mental Retardation, vol.107, issue.3, pp.222-232, 2002.

J. Hättenschwilera, P. Höcka, R. Luthera, J. Modestina, and E. Seifritzb, Bipolar disorder: Diagnosis, Swiss Medical Forum/Schweizerisches Medizin-Forum, vol.9, issue.42, p.64, 2009.

P. Hawe and A. Shiell, Social capital and health promotion: A review, Social Science & Medicine, vol.51, issue.6, p.61, 2000.

J. J. Heckman, R. J. Lalonde, and J. A. Smith, The economics and econometrics of active labor market programs, Handbook of Labor Economics, vol.3, p.92, 1999.

D. Hughes, B. Tunnage, and S. Yeo, Drugs for exceptionally rare diseases: Do they deserve special status for funding?, QJM, vol.98, issue.11, pp.829-836, 2005.

D. A. Hughes and J. Poletti-hughes, Profitability and market value of orphan drug companies: A retrospective, propensity-matched case-control study, PLOS One, vol.11, issue.10, p.46, 2016.

D. A. Hughes, B. Tunnage, and S. T. Yeo, Drugs for exceptionally rare diseases: Do they deserve special status for funding? QJM, An International Journal of Medicine, vol.98, issue.11, pp.829-836, 2005.

R. A. Hummer and J. T. Lariscy, Educational attainment and adult mortality, International Handbook of Adult Mortality, p.58, 2011.

E. L. Idler and Y. Benyamini, Self-rated health and mortality: A review of twenty-seven community studies, Journal of Health and Social Behavior, vol.87, pp.21-37, 1997.

G. W. Imbens and J. M. Wooldridge, Recent developments in the econometrics of program evaluation, Journal of Economic Literature, vol.47, issue.1, pp.5-86, 2009.

S. Jang, J. Nam, J. Choi, and E. Park, Disease management index of potential years of life lost as a tool for setting priorities in national disease control using OECD health data, Health Policy, vol.115, issue.1, p.203, 2014.

K. Jayasundara, A. Hollis, M. Krahn, M. Mamdani, J. S. Hoch et al., Estimating the clinical cost of drug development for orphan versus non-orphan drugs, Orphanet Journal of Rare Diseases, vol.14, issue.1, 2019.

M. Jeantet, A. Lopez, and N. Destais, Evaluation médico-économique en santé. Rapport Inspection générale des affaires sociales, vol.243, p.244, 2014.

A. R. Jensen, H. M. Nellemann, and J. Overgaard, Tumor progression in waiting time for radiotherapy in head and neck cancer, Radiotherapy and Oncology, vol.84, issue.1, p.42, 2007.

G. Johnson, G. Smith, A. Dramis, and R. Grimer, Delays in referral of soft tissue sarcomas, Sarcoma, p.70, 2008.

D. W. Johnston, G. Lordan, M. A. Shields, and A. Suziedelyte, Education and health knowledge: Evidence from UK compulsory schooling reform, Social Science & Medicine, vol.127, pp.92-100, 2015.

P. D. Joseph, J. C. Craig, and P. H. Caldwell, Clinical trials in children, British Journal of Clinical Pharmacology, vol.79, issue.3, pp.357-369, 2015.

F. Jusot and M. Khlat, The role of time and risk preferences in smoking inequalities: A population-based study, Addictive Behaviors, vol.38, issue.5, p.65, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01526058

F. Jusot, S. Tubeuf, and A. Trannoy, Circumstances and efforts: How important is their correlation for the measurement of inequality of opportunity in health?, Health Economics, vol.22, issue.12, pp.1470-1495, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01526037

D. Kahneman and S. Frederick, Representativeness revisited: Attribute substitution in intuitive judgment, Heuristics and Biases: The Psychology of Intuitive Judgment, vol.49, p.61, 2002.

J. Karnon, L. Edney, A. , and H. , The political economy of the assessment of value of new health technologies, pp.1355819617751816-248, 2018.

I. Kawachi, S. V. Subramanian, K. , and D. , Social capital and health. Social Capital and Health, vol.58, pp.1-26, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01471470

M. Kelly-irving, C. Delpierre, A. Schieber, B. Lepage, C. Rolland et al., Do general practitioners overestimate the health of their patients with lower education?, Social Science & Medicine, vol.73, issue.9, pp.1416-1421, 2011.

D. S. Kenkel, Health behavior, health knowledge, and schooling, Journal of Political Economy, vol.99, issue.2, pp.287-305, 1991.

I. Kennedy, Appraising the value of innovation and other benefits. A short study for NICE, p.246, 2009.

. Bibliography,

H. Kim, J. Greenberg, M. Seltzer, and M. Krauss, The role of coping in maintaining the psychological well-being of mothers of adults with intellectual disability and mental illness, Journal of Intellectual Disability Research, vol.47, issue.4-5, pp.313-327, 2003.

M. S. Kimball, Making sense of two-sided altruism, Journal of Monetary Economics, vol.20, issue.2, pp.301-326, 1987.

P. Kind, P. Dolan, C. Gudex, W. , and A. , Variations in population health status: Results from a United Kingdom national questionnaire survey, British Medical Journal, vol.316, issue.7133, p.43, 1998.

S. Kornrich, Inequalities in parental spending on young children, AERA Open, vol.2, issue.2, 1972.

T. Lang, P. Ducimetière, D. Arveiler, P. Amouyel, J. Ferrières et al., Is hospital care involved in inequalities in coronary heart disease mortality? Results from the french WHO-MONICA Project in men aged 30-64, Journal of Epidemiology & Community Health, vol.52, issue.10, pp.665-671, 1998.

T. Lang, B. Lepage, A. Schieber, S. Lamy, K. et al., Social determinants of cardiovascular diseases, Public Health Reviews, vol.33, issue.2, 2011.

A. Laporte and F. Windmeijer, Estimation of panel data models with binary indicators when treatment effects are not constant over time, Economics Letters, vol.88, issue.3, pp.389-396, 2005.

D. Lathyris, O. A. Panagiotou, M. Baltogianni, J. P. Ioannidis, and D. G. Contopoulos-ioannidis, Safety of medical interventions in children versus adults, Pediatrics, vol.133, issue.3, pp.666-673, 2014.

M. Laudicella, L. Siciliani, C. , and R. , Waiting times and socioeconomic status: Evidence from England, Social Science & Medicine, vol.74, issue.9, pp.1331-1341, 2012.

L. Fur, P. Yilmaz, and E. , Modes d'accès aux spécialistes en 2006 etévolution depuis la réforme de l'assurance maladie: Enquêtes santé protection sociale 2004 et 2006. Questions d'économie de la santé, pp.1-8, 2008.

M. Lechner and A. Strittmatter, Practical procedures to deal with common support problems in matching estimation, Econometric Reviews, vol.96, pp.1-15, 2017.

M. Lechner and R. Vazquez-alvarez, The effect of disability on labour market outcomes in Germany: The effects of matching, centre for economic policy research, 2004.

M. Lechner and C. Wunsch, Sensitivity of matching-based program evaluations to the availability of control variables, Labour Economics, vol.21, pp.111-121, 2013.

Y. Lee, The predictive value of self assessed general, physical, and mental health on functional decline and mortality in older adults, Journal of Epidemiology & Community Health, vol.54, issue.2, pp.123-129, 2000.

A. Lefranc, N. Pistolesi, and A. Trannoy, Equality of opportunity and luck: Definitions and testable conditions, with an application to income in france, Journal of Public Economics, vol.93, p.163, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01650733

A. Lefranc, N. Pistolesi, and A. Trannoy, Equality of opportunity and luck: Definitions and testable conditions, with an application to income in France, Journal of Public Economics, vol.93, pp.1189-1207, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01650733

A. Lefranc and A. Trannoy, Equality of Opportunity: How to encompass Fifty Shades of Luck. Working Papers 394, ECINEQ, Society for the Study of Economic Inequality, p.162, 2016.

J. Li and N. Powdthavee, Does more education lead to better health habits? Evidence from the school reforms in Australia, Social Science & Medicine, vol.127, pp.83-91, 2015.

F. R. Lichtenberg, The allocation of publicly funded biomedical research, Medical Care Output and Productivity, p.156, 2001.

F. R. Lichtenberg, The effect of new drugs on mortality from rare diseases and HIV, p.203, 2001.

F. R. Lichtenberg, Pharmaceutical innovation and the burden of disease in developing and developed countries, Journal of Medicine and Philosophy, vol.30, issue.6, pp.663-690, 2005.

F. R. Lichtenberg, The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, The European Journal of Health Economics, vol.14, issue.1, p.212, 1999.

F. R. Lichtenberg, The impact of pharmaceutical innovation on longevity and medical expenditure in France, Economics & Human Biology, vol.13, pp.107-127, 2000.

F. R. Lichtenberg, Pharmaceutical innovation and longevity growth in 30 developing and highincome countries, Health Policy and Technology, vol.3, issue.1, pp.36-58, 2000.

F. R. Lichtenberg, The impact of public and private research support on premature cancer mortality and hospitalization in the US, p.213, 1999.

F. R. Lichtenberg, The impact of public and private research on premature cancer mortality and hospitalization in the United States, The American Economist, vol.129, p.213, 1999.

F. R. Lichtenberg, The long-run impact of new medical ideas on cancer survival and mortality, Economics of Innovation and New Technology, vol.213, pp.1-19, 2018.

F. R. Lichtenberg and S. Virabhak, Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as" equipment for your health, p.153, 2002.

F. R. Bibliography-lichtenberg and J. Waldfogel, Does misery love company? evidence from pharmaceutical markets before and after the orphan drug act, National Bureau of Economic Research, vol.124, p.202, 2003.

P. Llorca, V. Camus, P. Courtet, D. Gourion, M. Lukasiewicz et al., Caractéristiques et modalités de prise en charge des patients présentant un trouble bipolaire en france: enquête montra, L'Encéphale, vol.39, issue.3, pp.212-223, 2013.

K. Logviss, D. Krievins, and S. Purvina, Characteristics of clinical trials in rare vs. common diseases: A register-based Latvian study, PloS One, vol.13, issue.4, p.202, 2018.

J. López-bastida, J. Ramos-goñi, I. Aranda-reneo, M. Trapero-bertran, P. Kanavos et al., Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases? Health Policy, vol.31, p.50, 2018.

Á. Lublóy, Factors affecting the uptake of new medicines: A systematic literature review, BMC Health Services Research, vol.14, issue.1, pp.469-214, 2014.

D. Lupton, Consumerism, reflexivity and the medical encounter, Social Science & Medicine, vol.45, issue.3, pp.373-381, 1997.

L. Luzzatto, C. E. Hollak, T. M. Cox, A. Schieppati, C. Licht et al., Rare diseases and effective treatments: Are we delivering? The Lancet, vol.385, p.44, 2015.

L. Luzzatto, H. I. Hyry, A. Schieppati, E. Costa, S. Simoens et al., Outrageous prices of orphan drugs: A call for collaboration, The Lancet, vol.392, p.202, 2018.

M. Seltzer, M. Greenberg, J. S. Floyd, F. J. Pettee, Y. Hong et al., Life course impacts of parenting a child with a disability, American journal on Mental Retardation, vol.106, issue.3, pp.265-286, 2001.

O. Manor, S. Matthews, and C. Power, Self-rated health and limiting longstanding illness: interrelationships with morbidity in early adulthood, International Journal of Epidemiology, vol.30, issue.3, pp.600-607, 2001.

C. F. Manski, Economic analysis of social interactions, Journal of Economic Perspectives, vol.14, issue.3, pp.115-136, 2000.

M. Marmot, Social determinants of health inequalities, The Lancet, vol.365, issue.9464, p.42, 2005.

K. O. Mason and K. Kuhlthau, The perceived impact of child care costs on women's labor supply and fertility, Demography, vol.29, issue.4, pp.523-543, 1992.

C. Mccabe, K. Claxton, and A. J. Culyer, The NICE cost-effectiveness threshold, 2008.

, Pharmacoeconomics, vol.26, issue.9, p.251

C. Mccabe, K. Claxton, and A. Tsuchiya, Orphan drugs and the NHS: Should we value rarity?, BMJ: British Medical Journal, vol.331, issue.7523, 2005.

W. I. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. Hartung et al., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis, Annals of Neurology, vol.50, issue.1, pp.121-127, 2001.

J. Mckie and J. Richardson, The rule of rescue, Social Science & Medicine, vol.56, issue.12, pp.2407-2419, 2003.

O. Michael, Prioritarianism and the measure of utility, Journal of Political Philosophy, vol.23, issue.1, pp.1-22, 2013.

L. Møller, T. S. Kristensen, and H. Hollnagel, Self rated health as a predictor of coronary heart disease in Copenhagen, Denmark, Journal of Epidemiology & Community Health, vol.50, issue.4, pp.423-428, 1996.

E. Mossialos and D. King, Citizens and rationing: Analysis of a European survey, Health Policy, vol.49, issue.1-2, pp.75-135, 1999.

K. M. Murphy and R. H. Topel, The value of health and longevity, Journal of Political Economy, vol.114, issue.5, pp.871-904, 2006.

N. A. Murphy, B. Christian, D. A. Caplin, Y. , and P. C. , The health of caregivers for children with disabilities: Caregiver perspectives. Child: Care, Health and Development, vol.33, pp.180-187, 2007.

S. Mustillo, L. R. Landerman, and K. C. Land, Modeling longitudinal count data: Testing for group differences in growth trajectories using average marginal effects, Sociological Methods & Research, vol.41, issue.3, pp.467-487, 2012.

S. Nestler-parr, D. Korchagina, M. Toumi, C. L. Pashos, C. Blanchette et al., Challenges in research and health technology assessment of rare disease technologies: report of the ispor rare disease special interest group, Value in Health, vol.21, issue.5, p.45, 2018.

, Guide to the methods of technology appraisal. London: Nice, p.244, 2004.

, Changes to NICE drug appraisals: What you need to know, p.247, 2017.

H. M. Nicholl and C. M. Begley, Explicating caregiving by mothers of children with complex needs in Ireland: A phenomenological study, Journal of Pediatric Nursing, vol.27, issue.6, pp.642-651, 2012.

E. Nicod, Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries, The European Journal of Health Economics, vol.18, issue.6, p.48, 2017.

D. Nutbeam, The evolving concept of health literacy, Social Science & Medicine, vol.67, issue.12, pp.2072-2078, 2008.

D. Nutbeam and I. Kickbusch, Advancing health literacy: A global challenge for the 21st century, vol.59, 2000.

K. M. Bibliography-olsen and S. Dahl, Health differences between European countries, Social Science & medicine, vol.64, issue.8, pp.1665-1678, 2007.

P. Oreopoulos, Estimating average and local average treatment effects of education when compulsory schooling laws really matter, The American Economic Review, vol.96, issue.1, pp.152-175, 2006.

F. Pammolli, L. Magazzini, and M. Riccaboni, The productivity crisis in pharmaceutical R&D, Nature Reviews Drug Discovery, vol.10, issue.6, 2011.

M. Paulden, Recent amendments to NICE's value-based assessment of health technologies: Implicitly inequitable? Taylor & Francis, vol.156, p.157, 2017.

M. Paulden, J. F. O'mahony, A. J. Culyer, and C. Mccabe, Some inconsistencies in NICE's consideration of social values, Pharmacoeconomics, vol.32, issue.11, 2014.

J. M. Perrin, L. E. Anderson, and J. Van-cleave, The rise in chronic conditions among infants, children, and youth can be met with continued health system innovations, vol.33, pp.2099-2105, 2014.

G. Picone, F. Sloan, T. , and D. , Effects of risk and time preference and expected longevity on demand for medical tests, Journal of Risk and Uncertainty, vol.28, issue.1, p.69, 2004.

J. Pomerleau, C. Knai, and E. Nolte, The burden of chronic disease in Europe. Caring for People with Chronic Conditions. A Health Systems Perspective, vol.84, pp.15-42, 2008.

A. P. Prayle, M. N. Hurley, and A. R. Smyth, Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: Cross sectional study, BMJ, vol.344, 2012.

R. D. Putnam, Bowling alone: America's declining social capital, Journal of Democracy, vol.6, issue.1, p.61, 1995.

R. D. Putnam and J. F. Helliwell, Education and Social Capital, National Bureau of Economic Research, vol.62, 1999.

V. Raimond, F. Midy, C. Thébaut, and C. Rumeau-pichon, L'évaluationéconomique des produits de santé innovants: quelle interprétation pour quel usage? Revue française des affaires sociales, vol.243, pp.263-281, 2016.

R. Ali, S. Radoszycki, L. Dourgnon, P. Rochaix, L. Chekroun et al., Accurate representation of patients' opinions for decision-making: Are online health communities good candidates? Diabetes, vol.2, p.66, 2017.

R. Ali, S. Raimond, V. Degrassat-théas, A. Jacquet, L. R. Rochaix et al., Early access schemes and pricing strategies: A case study on temporary authorization for use in France from, Revue française des affaires sociales, vol.258, pp.69-89, 1994.
URL : https://hal.archives-ouvertes.fr/halshs-02096440

R. Ali, S. Tubeuf, and S. , ). (In)-equality in the allocation of R&R resources for rare diseases, Social Justice Research, vol.36, pp.1-41, 2019.

M. Ramos, M. Esteva, E. Cabeza, C. Campillo, J. Llobera et al., Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: A review, European Journal of Cancer, vol.43, issue.17, pp.2467-2478, 2007.

D. G. Rand, V. L. Brescoll, J. A. Everett, V. Capraro, and H. Barcelo, Social heuristics and social roles: Intuition favors altruism for women but not for men, Journal of Experimental Psychology: General, vol.145, issue.4, pp.389-97, 2016.

T. Rapp, Patients' diagnosis decisions in Alzheimer's disease: The influence of family factors, Social Science & Medicine, vol.118, pp.9-16, 2014.

M. D. Rawlins and A. J. Culyer, National Institute for Clinical Excellence and its value judgments, BMJ: British Medical Journal, vol.329, issue.7459, p.246, 2004.

L. D. Ray, Parenting and childhood chronicity: Making visible the invisible work, Journal of Pediatric Nursing, vol.17, issue.6, pp.424-438, 2002.

R. L. Repetti, S. E. Taylor, and T. E. Seeman, Risky families: Family social environments and the mental and physical health of offspring, Psychological Bulletin, vol.128, issue.2, 2002.

M. A. Richard, J. J. Grob, M. F. Avril, M. Delaunay, J. Gouvernet et al., Delays in diagnosis and melanoma prognosis (i): The role of patients, International Journal of Cancer, vol.89, issue.3, pp.271-279, 2000.

M. Richards, A. Westcombe, S. Love, P. Littlejohns, and A. Ramirez, Influence of delay on survival in patients with breast cancer: A systematic review, The Lancet, vol.353, issue.9159, pp.1119-1126, 1999.

T. Richter, S. Nestler-parr, R. Babela, Z. M. Khan, T. Tesoro et al., , 2015.

, Rare disease terminology and definitions-A systematic global review: Report of the ISPOR rare disease special interest group, Value in Health, vol.18, issue.6, p.45

R. T. Riphahn, Income and employment effects of health shocks: A test case for the German welfare state, Journal of Population Economics, vol.12, issue.3, pp.363-389, 1999.

L. Rocco and E. Fumagalli, The empirics of social capital and health. The Economics of Social Capital and Health: A Conceptual and Empirical Roadmap, p.61, 2014.

L. Rocco, E. Fumagalli, and M. Suhrcke, From social capital to health-and back, Health economics, vol.23, issue.5, p.61, 2014.

L. Rochaix, Asymétries d'information et incertitude en santé: les apports de la théorie des contrats, Economie & prévision, vol.129, issue.3, pp.11-24, 1997.

C. Rodwell and S. Aymé, Rare disease policies to improve care for patients in Europe, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol.1852, issue.10, p.118, 2015.

J. E. Roemer, Equality of Opportunity. Cambridge, vol.162, p.171, 1998.
URL : https://hal.archives-ouvertes.fr/hal-01456129

J. Bibliography-rogge and B. Kittel, Who shall not be treated: Public attitudes on setting health care priorities by person-based criteria in 28 nations, PloS one, vol.11, issue.6, 2016.

P. R. Rosenbaum and D. B. Rubin, The central role of the propensity score in observational studies for causal effects, Biometrika, vol.70, issue.1, pp.41-55, 1983.

P. R. Rosenbaum and D. B. Rubin, Reducing bias in observational studies using subclassification on the propensity score, Journal of the American Statistical Association, vol.79, issue.387, pp.516-524, 1984.

D. B. Rubin and N. Thomas, Combining propensity score matching with additional adjustments for prognostic covariates, Journal of the American Statistical Association, vol.95, issue.450, pp.573-585, 2000.

R. M. Scheffler, T. T. Brown, and J. K. Rice, The role of social capital in reducing nonspecific psychological distress: The importance of controlling for omitted variable bias, Social Science & Medicine, vol.65, issue.4, pp.842-854, 2007.

R. H. Scheuermann, W. Ceusters, and B. Smith, Toward an ontological treatment of disease and diagnosis, Summit on translational bioinformatics, vol.24, p.40, 2009.

A. Schieppati, J. Henter, E. Daina, A. , and A. , Why rare diseases are an important medical and social issue, The Lancet, vol.371, issue.9629, p.152, 2008.

H. Schmitz and M. Westphal, Short-and medium-term effects of informal care provision on female caregivers' health, Journal of Health Economics, vol.42, pp.174-185, 2015.

F. Scott-morton and M. Kyle, Chapter Twelve -Markets for Pharmaceutical Products, Handbook of Health Economics, vol.2, p.152, 2011.

D. J. Sheskin, Handbook of parametric and nonparametric statistical procedures, p.161, 2003.

Y. T. Shih and M. Tai-seale, Physicians' perception of demand-induced supply in the information age: A latent class model analysis, Health Economics, vol.21, issue.3, pp.252-269, 2012.

S. Simoens, Pricing and reimbursement of orphan drugs: The need for more transparency, Orphanet Journal of Rare Diseases, vol.6, issue.1, p.50, 2011.

S. K. Smith, A. Dixon, L. Trevena, D. Nutbeam, and K. J. Mccaffery, Exploring patient involvement in healthcare decision making across different education and functional health literacy groups, Social Science & Medicine, vol.69, issue.12, pp.1805-1812, 2009.

C. Sorenson, M. Drummond, and P. Kanavos, Ensuring value for money in health care: The role of health technology assessment in the European Union. Number 11. WHO Regional Office Europe, vol.31, p.48, 2008.

M. Stabile and S. Allin, The economic costs of childhood disability. The Future of Children, vol.85, pp.65-96, 2012.

T. Stafinski, D. Menon, D. J. Philippon, and C. Mccabe, Health technology funding decisionmaking processes around the world, Pharmacoeconomics, vol.29, issue.6, pp.475-495, 2011.

E. A. Stolk, G. Van-donselaar, W. B. Brouwer, and J. J. Busschbach, Reconciliation of economic concerns and health policy, Pharmacoeconomics, vol.22, issue.17, pp.1097-1107, 2004.

J. K. Stoller, The challenge of rare diseases, Chest, vol.153, issue.6, p.45, 2018.

J. K. Stoller, R. A. Sandhaus, G. Turino, R. Dickson, K. Rodgers et al., Delay in diagnosis of ?1-antitrypsin deficiency: A continuing problem, Chest, vol.128, issue.4, p.45, 2005.

J. K. Stoller, P. Smith, P. Yang, and J. Spray, Physical and social impact of alpha 1-antitrypsin deficiency: Results of a survey, Cleveland Clinic Journal of Medicine, vol.61, issue.6, p.45, 1994.

L. Sundmacher, The effect of health shocks on smoking and obesity, The European Journal of Health Economics, vol.13, issue.4, pp.451-460, 2012.

A. Szende, M. Oppe, and N. Devlin, EQ-5D value sets: Inventory, comparative review and user guide, vol.2, p.240, 2007.

J. M. Talarico, K. S. Labar, and D. C. Rubin, Emotional intensity predicts autobiographical memory experience, Memory & Cognition, vol.32, issue.7, pp.1118-1132, 2004.

V. Tejwani, C. Sanders, E. Fye, A. Nowacki, and J. Stoller, Symptom and airflow correlates of delayed diagnosis in alpha-1 antitrypsin deficiency, Chest, vol.152, issue.4, p.45, 2017.

L. S. Temkin, Equality, priority or what?, Economics and Philosophy, vol.19, issue.1, p.156, 2003.

C. Thébaut and J. Wittwer, Taking redistributive principles into account in the economic evaluation of health care: A review of available methods. Revue française des affaires sociales, vol.156, pp.169-191, 2017.

P. Thokala, J. Ochalek, A. A. Leech, and T. Tong, Cost-effectiveness thresholds: The past, the present and the future, PharmacoEconomics, vol.244, pp.1-14, 2018.

A. Towse and P. Barnsley, Clarifying meanings of absolute and proportional shortfall with examples. Office of Health Economics, vol.17, p.247, 2013.

A. Towse, C. Pritchard, and N. J. Devlin, Cost-effectiveness thresholds: Economic and ethical issues. King's Fund, p.245, 2002.

A. Trannoy, S. Tubeuf, F. Jusot, and M. Devaux, Inequality of opportunities in health in France: A first pass, Health Economics, vol.19, issue.8, pp.921-938, 2010.

S. Tubeuf, Évaluationéconomique des technologies de santé du nice: un regard expert. Les Tribunes de la santé, p.241, 2010.

S. Tubeuf and R. Bell-aldeghi, Long-term effect of teenage birth on earnings: Evidence from a British cohort study, Oxford Economic Papers, vol.69, issue.3, pp.758-781, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01700752

S. Bibliography-tubeuf, F. Jusot, and D. Bricard, Mediating role of education and lifestyles in the relationship between early-life conditions and health: Evidence from the 1958 British cohort, Health Economics, vol.21, pp.129-150, 2012.

S. Tubeuf, E. Saloniki, and D. Cottrell, Parental health spillover in cost-effectiveness analysis: Evidence from self-harming adolescents in england, PharmacoEconomics, vol.37, issue.4, p.44, 2019.

L. Vallejo-torres, B. García-lorenzo, I. Castilla, C. Valcárcel-nazco, L. García-pérez et al., On the estimation of the cost-effectiveness threshold: Why, what, how? Value in Health, vol.19, p.241, 2016.

G. Van-assche, A. Dignass, W. Reinisch, C. J. Van-der-woude, A. Sturm et al., The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Special situations, Journal of Crohn's and Colitis, vol.4, issue.1, pp.63-101, 2010.

J. Van-cleave, S. L. Gortmaker, and J. M. Perrin, Dynamics of obesity and chronic health conditions among children and youth, Jama, vol.303, issue.7, pp.623-630, 2010.

S. Verba, K. L. Schlozman, and H. E. Brady, Voice and equality: Civic voluntarism in American politics, p.62, 1995.

J. E. Ware, M. Kosinski, and S. D. Keller, A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity, Medical Care, vol.34, issue.3, pp.220-233, 1996.

J. E. Ware and C. D. Sherbourne, The mos 36-item short-form health survey (sf-36): I. conceptual framework and item selection, Medical care, vol.87, pp.473-483, 1992.

M. C. Weinstein and W. B. Stason, Foundations of cost-effectiveness analysis for health and medical practices, New England Journal of Medicine, vol.296, issue.13, pp.716-721, 1977.

O. Wellman-labadie and Y. Zhou, The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity? Health Policy, vol.95, pp.216-228, 2010.

, Social determinants of health, WHO, vol.26, p.42, 2008.

R. G. Wilkinson and M. Marmot, Social determinants of health: The solid facts. World Health Organization, vol.26, p.42, 2003.

S. Willems, S. De-maesschalck, M. Deveugele, A. Derese, D. Maeseneer et al., Socio-economic status of the patient and doctor-patient communication: Does it make a difference?, Patient Education and Counseling, vol.56, issue.2, pp.139-146, 2005.

A. Williams, Intergenerational equity: An exploration of the 'fair innings' argument, Health Economics, vol.6, issue.2, pp.117-132, 1997.

A. Williams, The rationing debate. Rationing health care by age: The case for, BMJ, vol.314, issue.7083, 1997.

A. Williams and R. Cookson, Equity in health, Handbook of Health Economics, vol.1, pp.1863-1910, 2000.

E. Wittenberg, A. Saada, and L. A. Prosser, How illness affects family members: A qualitative interview survey. The Patient-Patient-Centered Outcomes Research, vol.6, pp.257-268, 2013.

B. L. Wolfe and R. H. Haveman, Social and nonmarket benefits from education in an advanced economy, Conference Series -Federal Reserve Bank of Boston, vol.47, p.60, 1998.

C. H. Wong, K. W. Siah, and A. W. Lo, Estimation of clinical trial success rates and related parameters, Biostatistics, vol.20, issue.2, p.138, 2019.

S. Wu, R. Wang, Y. Zhao, X. Ma, M. Wu et al., The relationship between selfrated health and objective health status: A population-based study, BMC Public Health, vol.13, issue.1, pp.320-87, 2013.

D. Yach, C. Hawkes, C. L. Gould, and K. J. Hofman, The global burden of chronic diseases: Overcoming impediments to prevention and control, Jama, vol.291, issue.21, p.44, 2004.

W. Yin, Market incentives and pharmaceutical innovation, Journal of Health Economics, vol.27, issue.4, p.202, 2008.